REDUVO

Trademark usage description

cannabinoid derived medicine for the treatment of aids-related loss of appetite and weight loss, and severe nausea and vomiting associated with cancer Read More

Classification Information

Class [005]
Cannabinoid derived medicine for the treatment of aids-related loss of appetite and weight loss, and severe nausea and vomiting associated with cancer chemotherapy.

Classification kind code

Mark Details

Serial Number

2074775

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 14 on 4^th Apr 2025	Default Notice Sent
Submitted for opposition 22 on 17^th Sept 2024	Search Recorded
Submitted for opposition 20 on 17^th Sept 2024	Examiner's First Report
Submitted for opposition 287 on 27^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 31^st Dec 2020	Filed
Submitted for opposition 1 on 31^st Dec 2020	Created
Submitted for opposition 31 on 31^st Dec 2020	Formalized